Answer
Plasma glucose should be monitored more closely when patients with diabetes start indacaterol maleate (Onbrez Breezhaler), as high inhaled doses of beta2-adrenergic agonists may increase plasma glucose; Onbrez Breezhaler has not been investigated in patients with poorly controlled diabetes.
Sources for this answer
- Onbrez Breezhaler 150 and 300 microgram inhalation powder, hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked